• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

medtech

How medtech companies can benefit from agile marketing

April 25, 2017 By Danielle Kirsh

digital marketing on iPad

Getting a medical device to market can be tough. It has to go through several hoops at the FDA, including the 5-step premarket requirements that include: classifying the device; choosing the correct premarket submission; preparing appropriate information for premarket FDA submission; sending a premarket submission to the FDA and communicating with FDA staff during review; and […]

Filed Under: Food & Drug Administration (FDA) Tagged With: agile marketing, incitriomarketing, medical device marketing, medtech

6 ways hydrogels are enabling medtech innovation

April 21, 2017 By Danielle Kirsh

Hydrogels are water-based biomaterials developed specifically for human use, according to a Biomaterials journal article. They are a water-swollen polymeric material that doesn’t change its distinct 3D structure. They are formed from super-absorbent, chain-like polymers and are not soluble in water. However, their porous surface allows for nutrients and cell waste to pass through. They have shown the […]

Filed Under: Featured, Hydrogels, Implants, Regenerative Medicine, Research & Development Tagged With: biomaterial, hydrogels, medtech, mit, Northwestern University, retinal detachment, robotics, University of Chicago, University of Tokyo

23andMe is back: FDA allows marketing of genetic health risk tests

April 21, 2017 By Chris Newmarker

23andMe

FDA this month allowed genetic testing company 23andMe to market genetic health risk tests for 10 diseases and conditions including Parkinson’s disease and late-onset Alzheimer’s disease. The de novo premarket review authorization, announced April 6, also included celiac disease, which results in the inability to digest gluten; alpha-1 antitrypsin deficiency, which raises the risk of […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: 23andme, FDA, medtech

Medtech stories we missed this week: April 14, 2017

April 14, 2017 By Danielle Kirsh

From FDA approvals to business expansion plans, here are medtech stories we missed this week but thought were still worth mentioning. 1. BioTelemetry launches offer to acquire LifeWatch BioTelemetry and LifeWatch announced in an April 9 press release that the 2 companies have entered a transaction agreement that states BioTelemetry will launch a tender offer to acquire all […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Optical/Ophthalmic, Research & Development, Wound Care Tagged With: Acelity, BioTelemetry, CollPlant, LifeWatch, medtech, Second Sight, Sight Science, Toshiba Medical

How Boston Sci is getting drug-eluting stents and balloons into legs

April 13, 2017 By Chris Newmarker

Boston Scientific officials think they have a leg up when it comes to bringing drug-eluting technology to bear on peripheral artery disease. That’s because the medical device giant has decades of experience with balloons and drug-eluting stents used around the heart. When it comes to treating the narrowing arteries in the legs and thighs, Boston […]

Filed Under: Business/Financial News, Cardiovascular, Drug-Device Combinations, Featured, Stents, Vascular Tagged With: Boston Scientific, drug-eluting balloons, drug-eluting stents, medtech

Medtech stories we missed this week: April 7, 2017

April 7, 2017 By Danielle Kirsh

New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking. Here are some medtech stories we missed this week but thought were still worth mentioning. 1. AMNIOX touts new umbilical cord study AMNIOX Medical announced that it has published the results of 3 studies that demonstrate […]

Filed Under: Clinical Trials, Research & Development Tagged With: Aesculap Implant Systems, AMNIOX, AngioDynamics, Cianna Medical, InVivo Therapeutics, medtech, Nu-Med, Occlutech

How the CellMist SkinGun heals: a Q&A with RenovaCare’s CEO

April 5, 2017 By Chris Newmarker

RenovaCare CellMist SkinGun

Heather Thompson, Senior Editor When Thomas Bold joined RenovaCare in 2013, he was already familiar with its potentially groundbreaking technology. Bold had served as StemCell Systems CEO in Berlin for many years. He was involved in the development of the CellMist and SkinGun – the platform technologies for RenovaCare Inc. The technologies represent a shift in thinking about wound care, […]

Filed Under: Drug-Device Combinations, Featured, Stem Cells, Wound Care Tagged With: medtech, RenovaCare, stem cells, wound care

This contact lenses breakthrough could enable glucose monitoring

April 4, 2017 By Danielle Kirsh

Biosensing contact lenses may not be able to self-heal like “The Terminator,” but they could measure blood glucose and detect other signs of disease in the future. Oregon State University researchers are set to present a study that suggests transparent biosensors that are embedded into contact lenses could provide insight for doctors and patients without […]

Filed Under: Diabetes, Featured Tagged With: biosensors, contact lenses, Diabetes, Google, medtech, Novartis

Medtech stories we missed this week: March 31, 2017

March 31, 2017 By Danielle Kirsh

This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia. Here are medtech stories we missed this week but thought were still worth mentioning: 1. Corindus touts first Asian use of next-generation robot Corindus Vascular Robotics announced in a March 31 press release that robot-assisted […]

Filed Under: Business/Financial News, Clinical Trials, Food & Drug Administration (FDA), Personnel, Regulatory/Compliance, Research & Development Tagged With: Aminox, Bodycad, corindus, Engologix, medtech, NeoSurgical, NeoTract, Providence Medical, TissueTech

Skin sensors provide insights into how to treat Parkinson’s

March 27, 2017 By Danielle Kirsh

A University of Rochester research team is using wearable sensors to indicate the best individualized treatment of Parkinson’s disease. Bernadette Mroz suffers from Parkinson’s. When her medication isn’t working, it makes it hard for her to function. “My world goes into a spin cycle. I cannot function mentally, emotionally or physically,” said Mroz in a […]

Filed Under: Clinical Trials, Patient Monitoring Tagged With: Huntington's disease, machine learning algorithms, medtech, Parkinson's disease, skin sensors, University of Rochester, wearable sensors

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS